The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Guardant Health Inc (NASDAQ: GH) was $40.72 for the day, down -1.55% from the previous closing price of $41.36. In other words, the price has decreased by -$1.55 from its previous closing price. On the day, 1.39 million shares were traded. GH stock price reached its highest trading level at $42.25 during the session, while it also had its lowest trading level at $40.41.
Ratios:
Our analysis of GH’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.76 and its Current Ratio is at 4.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on April 10, 2025, initiated with a Outperform rating and assigned the stock a target price of $55.
On January 23, 2025, Barclays started tracking the stock assigning a Overweight rating and target price of $60.
Guggenheim Upgraded its Neutral to Buy on June 28, 2024, while the target price for the stock was maintained at $36.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 01 ’25 when Talasaz AmirAli sold 106,784 shares for $49.01 per share. The transaction valued at 5,233,421 led to the insider holds 2,202,672 shares of the business.
Talasaz AmirAli sold 13,932 shares of GH for $703,151 on May 02 ’25. The Co-Chief Executive Officer now owns 2,188,740 shares after completing the transaction at $50.47 per share. On May 01 ’25, another insider, Talasaz AmirAli, who serves as the Officer of the company, bought 340,000 shares for $49.01 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GH now has a Market Capitalization of 5044719616 and an Enterprise Value of 5652532224. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.52. Its current Enterprise Value per Revenue stands at 7.303 whereas that against EBITDA is -13.697.
Stock Price History:
The Beta on a monthly basis for GH is 1.39, which has changed by 0.5518292 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, GH has reached a high of $52.92, while it has fallen to a 52-week low of $20.14. The 50-Day Moving Average of the stock is -6.65%, while the 200-Day Moving Average is calculated to be 16.66%.
Shares Statistics:
GH traded an average of 2.39M shares per day over the past three months and 3335790 shares per day over the past ten days. A total of 123.65M shares are outstanding, with a floating share count of 117.60M. Insiders hold about 5.07% of the company’s shares, while institutions hold 95.78% stake in the company. Shares short for GH as of 1745971200 were 7711131 with a Short Ratio of 3.23, compared to 1743379200 on 8281364. Therefore, it implies a Short% of Shares Outstanding of 7711131 and a Short% of Float of 6.54.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
